Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07681804 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Betamethasone vs Dextrose Injections in Trigger Finger

StatusRecruiting
PhaseNot applicable
Started2026-06-30
View on ClinicalTrials.gov ↗

Amendment history

2026-07-26
notable
Study Status, Contacts/Locations v2
Recruitment opened
Start dateestimated 2026-06→confirmed 2026-06-30
Study sitesdetails revised at 1 of 1 site
2026-07-05
minor
Study Status, Sponsor/Collaborators, IPDSharing v1
Re-verified, no change to tracked fields
2026-06-27
minor
Original filing
This study aims to compare the effectiveness of ultrasound-guided betamethasone and dextrose injections in patients with trigger finger. Trigger finger is a common hand condition characterized by pain, clicking, and locking of the finger due to tendon entrapment at the A1 pulley. Corticosteroid injections are widely used as a first-line treatment; however, they may be associated with potential side effects. Dextrose injection is an alternative treatment that may promote tissue healing through regenerative mechanisms. However, there is limited high-quality evidence regarding its effectiveness in trigger finger. In this randomized controlled trial, patients will be assigned to receive either betamethasone or dextrose injection under ultrasound guidance. The primary outcome will be pain intensity measured by the Numeric Rating Scale (NRS). Secondary outcomes will include triggering severity, hand function, grip and pinch strength, and fine motor skills evaluated over a 12-week follow-up period. The results of this study may help determine whether dextrose injection is a safe and effective alternative to corticosteroid treatment in trigger finger.
Trial Details
NCT Number NCT07681804
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Trigger Finger
Enrollment 42 participants
Start Date 2026-06-30
Primary Completion 2027-04 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-28